/R E P E A T -- Media Advisory - Ronnie Miller, President & CEO of Roche Canada, at the Canadian Club of Montreal's podium/ Speech title: The Role of Roche in Sustaining Pharmaceutical Innovation in Quebec MONTREAL, April 8, 2013 /CNW Telbec/ - Monday, April 15, 2013 Noon - 2 p.m. (speech at 1 p.m.) Le Centre Sheraton Montreal Hotel Ballroom 1201, René-Lévesque W. blvd, Montréal Roche's presence in Montreal goes back more than 80 years, since Hoffmann-La Roche was incorporated here in 1931. Today, Roche's footprint in Montreal includes the partnership with the Montreal Heart Institute as Roche's global hub of translational medicine in cardiovascular medicine. This affiliation demonstrates Roche's continuing commitment to the province's pharmaceutical industry. As the pharmaceutical industry evolves, there are several challenges and opportunities facing the healthcare sector over the coming years, in both Canada and worldwide. As a leader in both pharmaceuticals and diagnostics, Roche is uniquely positioned to provide patients with truly individualized treatment and better outcomes. We hope to have the pleasure of welcoming you to this most interesting luncheon presentation. Roxane Gélinas Coordinator -Events Canadian Club of Montreal 514 398-0333 firstname.lastname@example.org A photographer will be on site. Please email@example.com for more information. SOURCE: Canadian Club of Montreal To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/April2013/15/c3205.html CO: Canadian Club of Montreal ST: Quebec NI: FIN MED -0- Apr/15/2013 09:59 GMT
/R E P E A T -- Media Advisory - Ronnie Miller, President & CEO of Roche Canada, at the Canadian Club of Montreal's podium/
Press spacebar to pause and continue. Press esc to stop.